Tokyo, June 16, 2006 (JCN) - Novartis Pharma has obtained additional approval for Neoral (cyclosporine), its proprietary immunosuppressant, from the Ministry of Health, Labor and Welfare. The agent is now available for the treatment of generalized myasthenia gravis.
